Literature DB >> 1779875

Physiological effects of the lipopolysaccharide of Vibrio vulnificus on mice and rats.

V L McPherson1, J A Watts, L M Simpson, J D Oliver.   

Abstract

Vibrio vulnificus is a pathogenic, marine, Gram-negative bacterium which commonly enters and infects humans via open wounds or the ingestion of raw seafood. The lipopolysaccharide (LPS) of V. vulnificus has recently been characterized, but the biological activity of this putative endotoxin is unknown. Three treatment groups were used to test its activity: saline (negative control), the LPS of Salmonella typhimurium (a known endotoxin), and the LPS of V. vulnificus. Whereas, intravenous injections of the S. typhimurium LPS caused mortality in two strains of mice, V. vulnificus LPS was not lethal. However, intraperitoneal injections into rats of both V. vulnificus and S. typhimurium LPS were pyrogenic. Intravenous injections of V. vulnificus LPS in rats caused decreased mean arterial pressure within 10 min which further declined, leading to death in 30 to 60 min. S. typhimurium LPS caused similar responses at the same concentration. The data suggest that the LPS of V. vulnificus may be a factor contributing to the virulence of this organism.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1779875

Source DB:  PubMed          Journal:  Microbios        ISSN: 0026-2633


  14 in total

Review 1.  Hepcidin: the missing link between hemochromatosis and infections.

Authors:  Houman Ashrafian
Journal:  Infect Immun       Date:  2003-12       Impact factor: 3.441

Review 2.  Vibrio vulnificus: disease and pathogenesis.

Authors:  Melissa K Jones; James D Oliver
Journal:  Infect Immun       Date:  2009-03-02       Impact factor: 3.441

3.  Essential role for estrogen in protection against Vibrio vulnificus-induced endotoxic shock.

Authors:  S M Merkel; S Alexander; E Zufall; J D Oliver; Y M Huet-Hudson
Journal:  Infect Immun       Date:  2001-10       Impact factor: 3.441

4.  Identification of a group 1-like capsular polysaccharide operon for Vibrio vulnificus.

Authors:  A C Wright; J L Powell; J B Kaper; J G Morris
Journal:  Infect Immun       Date:  2001-11       Impact factor: 3.441

5.  Identification of OmpU of Vibrio vulnificus as a fibronectin-binding protein and its role in bacterial pathogenesis.

Authors:  Sung Young Goo; Hyun-Ju Lee; Woo Hwang Kim; Kyu-Lee Han; Dae-Kyun Park; Hyun-Jung Lee; Sung Min Kim; Kun-Soo Kim; Kyu-Ho Lee; Soon-Jung Park
Journal:  Infect Immun       Date:  2006-10       Impact factor: 3.441

6.  Release of tumor necrosis factor alpha in response to Vibrio vulnificus capsular polysaccharide in in vivo and in vitro models.

Authors:  J L Powell; A C Wright; S S Wasserman; D M Hone; J G Morris
Journal:  Infect Immun       Date:  1997-09       Impact factor: 3.441

7.  A calcium-calmodulin antagonist blocks experimental Vibrio vulnificus cytolysin-induced lethality in an experimental mouse model.

Authors:  Young-Rae Lee; Kwang-Hyun Park; Zhao-Zhen Lin; Young-Jong Kho; Jin-Woo Park; Hye-Won Rho; Bon-Sun Koo; Hyung-Rho Kim; Eun-Kyung Song; Hong-Nu Yu; Myung-Kwan Han; Seung-Ok Lee; Eun-Chung Jhee; Jong-Suk Kim
Journal:  Infect Immun       Date:  2004-10       Impact factor: 3.441

8.  Ecology of Vibrio vulnificus in estuarine waters of eastern North Carolina.

Authors:  Courtney S Pfeffer; M Frances Hite; James D Oliver
Journal:  Appl Environ Microbiol       Date:  2003-06       Impact factor: 4.792

9.  Genetic variation in the Vibrio vulnificus group 1 capsular polysaccharide operon.

Authors:  Maria Chatzidaki-Livanis; Melissa K Jones; Anita C Wright
Journal:  J Bacteriol       Date:  2006-03       Impact factor: 3.490

10.  Comparative study of biological properties and electrophoretic characteristics of lipopolysaccharide from eel-virulent and eel-A virulent Vibrio vulnificus strains.

Authors:  E G Biosca; R M Collado; J D Oliver; C Amaro
Journal:  Appl Environ Microbiol       Date:  1999-02       Impact factor: 4.792

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.